These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16080811)
1. [Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]. Qin Q; Zhao BR; Mao YM; Cui RZ; Kou L; Li YL; Zhao FM; Hui RT Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):622-6. PubMed ID: 16080811 [TBL] [Abstract][Full Text] [Related]
2. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761 [TBL] [Abstract][Full Text] [Related]
3. A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome. Tian C; Qin W; Li L; Zheng W; Qiu F Biomed Pharmacother; 2010 Mar; 64(3):191-4. PubMed ID: 20137882 [TBL] [Abstract][Full Text] [Related]
4. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516 [TBL] [Abstract][Full Text] [Related]
5. Positive correlation between CD137 expression and complex stenosis morphology in patients with acute coronary syndromes. Yan J; Gong J; Liu P; Wang C; Chen G Clin Chim Acta; 2011 May; 412(11-12):993-8. PubMed ID: 21396356 [TBL] [Abstract][Full Text] [Related]
6. The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome. Liu DM; Yan JC; Wang CP; Chen GH; Ding S; Liu PJ; Du RZ Clin Chim Acta; 2008 Nov; 397(1-2):22-6. PubMed ID: 18674525 [TBL] [Abstract][Full Text] [Related]
7. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome. Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218 [TBL] [Abstract][Full Text] [Related]
8. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction. Koh YS; Chang K; Kim PJ; Seung KB; Baek SH; Shin WS; Lim SH; Kim JH; Choi KB Int J Cardiol; 2008 Jul; 127(3):430-2. PubMed ID: 17698228 [TBL] [Abstract][Full Text] [Related]
9. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). Bigalke B; Stellos K; Weig HJ; Geisler T; Seizer P; Kremmer E; Pötz O; Joos T; May AE; Lindemann S; Gawaz M Basic Res Cardiol; 2009 May; 104(3):352-7. PubMed ID: 19190951 [TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Bigalke B; Haap M; Stellos K; Geisler T; Seizer P; Kremmer E; Overkamp D; Gawaz M Thromb Res; 2010 May; 125(5):e184-9. PubMed ID: 20122713 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L; Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489 [TBL] [Abstract][Full Text] [Related]
12. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868 [TBL] [Abstract][Full Text] [Related]
13. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]. Gao B; Li ZC Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334 [TBL] [Abstract][Full Text] [Related]
15. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients. Gai X; Lan X; Luo Z; Wang F; Liang Y; Zhang H; Zhang W; Hou J; Huang M Clin Chim Acta; 2009 Oct; 408(1-2):105-9. PubMed ID: 19665460 [TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels. Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882 [TBL] [Abstract][Full Text] [Related]
17. The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes. Yan J; Zang X; Chen R; Yuan W; Gong J; Wang C; Li Y Clin Chim Acta; 2012 Apr; 413(7-8):691-5. PubMed ID: 22209965 [TBL] [Abstract][Full Text] [Related]
18. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome]. Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650 [TBL] [Abstract][Full Text] [Related]
19. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury. Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus. Wang Y; Su Y; Xu Y; Pan SH; Liu GD Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]